EA200001056A1 - Способ определения присутствия антигена папилломатозного дерматита в образце сыворотки жвачного животного - Google Patents

Способ определения присутствия антигена папилломатозного дерматита в образце сыворотки жвачного животного

Info

Publication number
EA200001056A1
EA200001056A1 EA200001056A EA200001056A EA200001056A1 EA 200001056 A1 EA200001056 A1 EA 200001056A1 EA 200001056 A EA200001056 A EA 200001056A EA 200001056 A EA200001056 A EA 200001056A EA 200001056 A1 EA200001056 A1 EA 200001056A1
Authority
EA
Eurasian Patent Office
Prior art keywords
dermatitis
ratic
papillomatosis
refractory
antigen
Prior art date
Application number
EA200001056A
Other languages
English (en)
Other versions
EA004873B1 (ru
Inventor
Дэйл Уоллис
Джеймс Л. Уоллис
Original Assignee
Дэйл Уоллис
Джеймс Л. Уоллис
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Дэйл Уоллис, Джеймс Л. Уоллис filed Critical Дэйл Уоллис
Publication of EA200001056A1 publication Critical patent/EA200001056A1/ru
Publication of EA004873B1 publication Critical patent/EA004873B1/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • General Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Food Science & Technology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)

Abstract

Настоящее изобретение относится к области обнаружения, предупреждения и/или лечения папилломатозного пальцевидного дерматита у жвачных животных с использованием новых штаммов бактерии Serpens spp., пригодных для указанного применения.Отчет о международном поиске был опубликован 1998.02.12.
EA200001056A 1996-08-01 1997-07-31 Способ определения присутствия антигена папилломатозного пальцевидного дерматита в образце сыворотки жвачного животного EA004873B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2291596P 1996-08-01 1996-08-01
PCT/US1997/012861 WO1998005755A1 (en) 1996-08-01 1997-07-31 Detection, prevention and treatment of papillomatous digital dermatitis

Publications (2)

Publication Number Publication Date
EA200001056A1 true EA200001056A1 (ru) 2001-04-23
EA004873B1 EA004873B1 (ru) 2004-08-26

Family

ID=21812090

Family Applications (2)

Application Number Title Priority Date Filing Date
EA199800243A EA002181B1 (ru) 1996-08-01 1997-07-31 Штамм бактерий serpens spp., фармацевтическая композиция, способы их применения и диагностический набор
EA200001056A EA004873B1 (ru) 1996-08-01 1997-07-31 Способ определения присутствия антигена папилломатозного пальцевидного дерматита в образце сыворотки жвачного животного

Family Applications Before (1)

Application Number Title Priority Date Filing Date
EA199800243A EA002181B1 (ru) 1996-08-01 1997-07-31 Штамм бактерий serpens spp., фармацевтическая композиция, способы их применения и диагностический набор

Country Status (19)

Country Link
US (2) US6162429A (ru)
EP (1) EP0863981B1 (ru)
JP (1) JP2000500027A (ru)
KR (1) KR19990063786A (ru)
CN (1) CN1198185A (ru)
AT (1) ATE443755T1 (ru)
AU (1) AU732317B2 (ru)
BR (1) BR9706543A (ru)
CA (1) CA2233570C (ru)
DE (1) DE69739592D1 (ru)
DK (1) DK0863981T3 (ru)
EA (2) EA002181B1 (ru)
ES (1) ES2336285T3 (ru)
IL (1) IL123922A (ru)
MX (1) MX9802543A (ru)
NZ (1) NZ330050A (ru)
PT (1) PT863981E (ru)
TR (1) TR199800597T1 (ru)
WO (1) WO1998005755A1 (ru)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6667040B2 (en) 1997-09-08 2003-12-23 University Technologies International, Inc. Bovine footrot treatment and prevention
US6241992B1 (en) * 1997-09-08 2001-06-05 University Technologies International, Inc. Bovine footrot treatment and prevention
US6287575B1 (en) * 1997-10-03 2001-09-11 The Regents Of The University Of California Vaccine against papillomatous digital dermatitis (PDD)
US7097861B1 (en) 2003-02-07 2006-08-29 Jones-Hamilton Co. Method of treating livestock footbath solutions
US8703104B2 (en) * 2007-10-25 2014-04-22 Ecolab Usa Inc Use of metal astringents for the treatment of hairy heel warts
US8697753B1 (en) 2013-02-07 2014-04-15 Polichem Sa Method of treating onychomycosis
US10022458B2 (en) 2015-03-05 2018-07-17 Iowa State University Research Foundation, Inc. Animal model protocol, diagnostic, therapeutic and vaccine against digital dermatitis

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1175516A (en) * 1966-04-15 1969-12-23 Science Union & Cie New Phenyl-Aminopropane Derivatives and Preparations Containing them
US3673205A (en) * 1970-03-25 1972-06-27 American Cyanamid Co 6-(m-AMINO AND SUBSTITUTED-AMINO PHENYL)-2,3,5,6-TETRAHYDRO{8 2,1-b{9 THIAZOLES AND METHOD OF USE
US4029763A (en) 1974-08-05 1977-06-14 Mount Sinai School Of Medicine Of The City University Of New York Influenza vaccine containing purified neuraminidase antigen and method of using the same
DE2930706A1 (de) * 1979-07-28 1981-02-05 Medac Klinische Spezialpraep Verfahren zum nachweis von erregerspezifischen antikoerpern
JPS6067474A (ja) * 1983-09-24 1985-04-17 Wakamoto Pharmaceut Co Ltd 新規な１，３，４−チアジアゾ−ル誘導体及びそれを有効成分とする抗潰瘍剤
US4746613A (en) * 1984-03-02 1988-05-24 Wichmann Robert W Poultry diseases bacterin preparation
US4879213A (en) * 1986-12-05 1989-11-07 Scripps Clinic And Research Foundation Synthetic polypeptides and antibodies related to Epstein-Barr virus early antigen-diffuse
US5630379A (en) * 1996-02-12 1997-05-20 Ssi Corporation Electrically controlled spraying device for cleaning and treating animals
US6287575B1 (en) * 1997-10-03 2001-09-11 The Regents Of The University Of California Vaccine against papillomatous digital dermatitis (PDD)

Also Published As

Publication number Publication date
PT863981E (pt) 2010-01-04
IL123922A (en) 2005-07-25
CA2233570C (en) 2013-02-19
US6162429A (en) 2000-12-19
NZ330050A (en) 2000-01-28
WO1998005755A1 (en) 1998-02-12
AU732317B2 (en) 2001-04-12
ES2336285T3 (es) 2010-04-09
CA2233570A1 (en) 1998-02-12
AU3809997A (en) 1998-02-25
EP0863981A1 (en) 1998-09-16
JP2000500027A (ja) 2000-01-11
EP0863981B1 (en) 2009-09-23
CN1198185A (zh) 1998-11-04
BR9706543A (pt) 1999-12-28
EA004873B1 (ru) 2004-08-26
EA002181B1 (ru) 2002-02-28
EP0863981A4 (en) 2002-09-18
DK0863981T3 (da) 2010-02-01
DE69739592D1 (de) 2009-11-05
US6884412B1 (en) 2005-04-26
TR199800597T1 (xx) 1998-06-22
MX9802543A (es) 1998-11-30
EA199800243A1 (ru) 1998-10-29
ATE443755T1 (de) 2009-10-15
KR19990063786A (ko) 1999-07-26

Similar Documents

Publication Publication Date Title
AU2002902A (en) Method for differentiating irritable bowel syndrome from inflammatory bowel disease (ibd) and for monitoring persons with ibd using total endogenous lactoferrinas a marker
ATE454163T1 (de) Bakterielle impfstoffe, enthaltend auxotrophe attenuierte listerienstämme, welche heterologe antigene exprimieren
CY1105025T1 (el) Αναλυση λεπτινης βασιζομενη στην ανιχνευση εκφρασης ang-2
HK1080506A1 (en) Fusion proteins of mycobacterium tuberculosis
WO1996012189A3 (en) METHODS OF SCREENING FOR ULCERATIVE COLITIS AND CROHN'S DISEASE BY DETECTING VH3-15 AUTOANTIBODY AND pANCA
DE69632625D1 (de) Mykrobakterielle proteine, mikroorganismen welche diese produzieren und ihre verwendung als impfstoff und zum nachweis von zuberkulose
NZ330475A (en) Antibodies, and use thereof in measuring lipid peroxidation in biological samples and method for inducing inflammation
EA200001056A1 (ru) Способ определения присутствия антигена папилломатозного дерматита в образце сыворотки жвачного животного
DE59509344D1 (de) Antikörperklassenspezifisches entstörungsreagenz
ATE319830T1 (de) Mutanten von streptococcaltoxin c und verfahren zu deren anwendung
ATE346860T1 (de) Mutanten von streptococcaltoxinen und vefahren zu deren anwendung
EA200500125A1 (ru) СПОСОБ ОБОГАЩЕНИЯ И ОБНАРУЖЕНИЯ ПАТОЛОГИЧЕСКИ ИЗМЕНЕННЫХ ПРИОНПРОТЕИНОВ (PrP)
ES2171913T3 (es) Procedimiento de puesta en evidencia de contaminantes microbiologicos vivos en una muestra de producto de uso alimentario.
PL337576A1 (en) Method of searching for compounds being useful in preventing infections and pathogenic effects
FI910358A0 (fi) Menetelmä mikro-organismien määrittämiseksi ja erottamiseksi
SE9603344D0 (sv) Method and apparatus for detecting substances
ZA955916B (en) Method for determining the lysine content of seeds
WO2003107007A3 (de) Schnelltestverfahren zum nachweis von mindestens einem antigen sowie dessen verwendung
Mazzolini et al. Use of agar gel immunodiffusion test to distinguish O 1 and O 2 Yersinia ruckeri serotypes.
NO904121L (no) Fremgangsmaate og apparat for innsamling og paavisning av mikroorganismer.
FI102217B1 (fi) Menetelmä Pseudomonas aeruginosa-serotyyppien toteamiseksi näytteestä in vitro monoklonaalisten vasta-aineiden avulla, menetelmässä käytettäviä monoklonaalisia vasta-aineita sekä menetelmässä käyttökelpoinen testipakkaus
EP0701699A1 (en) IMMUNOELECTROFORESE PROCEDURE
UA39967C2 (uk) Спосіб вимірювання параметрів нвч- сигналів та трактів
RU93036085A (ru) Способ идентификации мумиеобразных веществ

Legal Events

Date Code Title Description
MM4A Lapse of a eurasian patent due to non-payment of renewal fees within the time limit in the following designated state(s)

Designated state(s): AM AZ BY KZ KG MD TJ TM RU